» Articles » PMID: 11986252

Host Background Immunity and Human Immunodeficiency Virus Protective Vaccines, a Major Consideration for Vaccine Efficacy in Africa and in Developing Countries

Overview
Date 2002 May 3
PMID 11986252
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Alam M, Jarvis C, Hincapie R, McKay C, Schimer J, Sanhueza C ACS Nano. 2020; 15(1):309-321.

PMID: 32790346 PMC: 8249087. DOI: 10.1021/acsnano.0c03023.


High background in ELISpot assays is associated with elevated levels of immune activation in HIV-1-seronegative individuals in Nairobi.

Liu A, De Rosa S, Guthrie B, Choi R, Kerubo-Bosire R, Richardson B Immun Inflamm Dis. 2018; 6(3):392-401.

PMID: 29974672 PMC: 6113767. DOI: 10.1002/iid3.231.


Chronic Schistosoma japonicum infection reduces immune response to vaccine against hepatitis B in mice.

Chen L, Liu W, Lei J, Guan F, Li M, Song W PLoS One. 2012; 7(12):e51512.

PMID: 23272112 PMC: 3522692. DOI: 10.1371/journal.pone.0051512.


Elevation of immune activation in kenyan women is associated with alterations in immune function: implications for vaccine development.

Koesters S, Matu L, Kiama P, Anzala O, Embree J, Plummer F J Clin Immunol. 2004; 24(6):702-9.

PMID: 15622455 DOI: 10.1007/s10875-004-6238-1.


Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Borkow G, Bentwich Z Clin Microbiol Rev. 2004; 17(4):1012-30, table of contents.

PMID: 15489359 PMC: 523563. DOI: 10.1128/CMR.17.4.1012-1030.2004.

References
1.
Stadecker M, Hernandez H . The immune response and immunopathology in infection with Schistosoma mansoni: a key role of major egg antigen Sm-p40. Parasite Immunol. 1998; 20(5):217-21. DOI: 10.1046/j.1365-3024.1998.00150.x. View

2.
Stahl-Hennig C, Dittmer U, Nisslein T, Petry H, Jurkiewicz E, Fuchs D . Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. J Gen Virol. 1996; 77 ( Pt 12):2969-81. DOI: 10.1099/0022-1317-77-12-2969. View

3.
Clerici M, Giorgi J, Chou C, Gudeman V, Zack J, Gupta P . Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis. 1992; 165(6):1012-9. DOI: 10.1093/infdis/165.6.1012. View

4.
Fowke K, Nagelkerke N, Kimani J, Simonsen J, Anzala A, Bwayo J . Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996; 348(9038):1347-51. DOI: 10.1016/S0140-6736(95)12269-2. View

5.
Kalinkovich A, Maayan S, Weisman Z, Harpaz N, Bentwich Z . Immune activation, a co-factor for HIV transmission in Thailand?. Lancet. 1994; 343(8911):1506-7. DOI: 10.1016/s0140-6736(94)92618-2. View